Evan C. Chen

622 total citations
32 papers, 265 citations indexed

About

Evan C. Chen is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Evan C. Chen has authored 32 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 10 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Evan C. Chen's work include Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Evan C. Chen is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (6 papers). Evan C. Chen collaborates with scholars based in United States, Israel and Germany. Evan C. Chen's co-authors include Amir T. Fathi, Andrew M. Brunner, Jacqueline S. Garcia, Jong H. Yoon, Richard M. Stone, Daniel J. DeAngelo, Corey J. Keller, Maximilian Stahl, Jon P. Fryzek and Heidi Reichert and has published in prestigious journals such as Nature Genetics, Blood and Gastroenterology.

In The Last Decade

Evan C. Chen

30 papers receiving 262 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evan C. Chen United States	10	151	88	53	50	27	32	265
Maria Scalzone Italy	9	72 0.5×	78 0.9×	32 0.6×	51 1.0×	23 0.9×	15	309
Annalisa Paviglianiti Spain	10	155 1.0×	58 0.7×	28 0.5×	80 1.6×	30 1.1×	39	250
Eiju Negoro Japan	11	107 0.7×	136 1.5×	40 0.8×	79 1.6×	26 1.0×	39	318
Francesca Guidotti Italy	10	74 0.5×	40 0.5×	63 1.2×	27 0.5×	23 0.9×	23	214
Muhammad Ashar Ali United States	9	55 0.4×	63 0.7×	53 1.0×	73 1.5×	48 1.8×	41	298
Uroš Markovic Italy	8	95 0.6×	60 0.7×	33 0.6×	41 0.8×	24 0.9×	36	188
Aiko Kida Japan	10	138 0.9×	66 0.8×	38 0.7×	73 1.5×	52 1.9×	13	295
Lochie Teague New Zealand	12	169 1.1×	49 0.6×	29 0.5×	36 0.7×	19 0.7×	26	322
Min Ruan China	8	185 1.2×	96 1.1×	29 0.5×	71 1.4×	15 0.6×	66	303
Dae-Chul Jeong South Korea	11	215 1.4×	87 1.0×	67 1.3×	50 1.0×	16 0.6×	35	352

Countries citing papers authored by Evan C. Chen

Since Specialization

Citations

This map shows the geographic impact of Evan C. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan C. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan C. Chen more than expected).

Fields of papers citing papers by Evan C. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan C. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan C. Chen. The network helps show where Evan C. Chen may publish in the future.

Co-authorship network of co-authors of Evan C. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Evan C. Chen. A scholar is included among the top collaborators of Evan C. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan C. Chen. Evan C. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Evan C., Shai Shimony, Marlise R. Luskin, & Richard M. Stone. (2025). Biology and Management of Acute Myeloid Leukemia With Mutated NPM1. American Journal of Hematology. 100(4). 652–665. 1 indexed citations

Benfatto, Salvatore, Phillip Michaels, Christoph Schliemann, et al.. (2024). Rapid Epigenomic Classification of Acute Leukemia. Blood. 144(Supplement 1). 273–273. 1 indexed citations

Shimony, Shai, Jacqueline S. Garcia, Evan C. Chen, et al.. (2024). Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients. Leukemia. 38(7). 1494–1500. 14 indexed citations

Drygalski, Annette von, Aric Parnes, Evan C. Chen, et al.. (2024). Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort. Blood Advances. 8(22). 5896–5905. 1 indexed citations

Shimony, Shai & Evan C. Chen. (2024). Tri‐ing to decipher trisomy AML. British Journal of Haematology. 204(3). 751–752.

Shimony, Shai, Jan Philipp Bewersdorf, Rory M. Shallis, et al.. (2024). Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML. Leukemia. 38(4). 762–768. 17 indexed citations

Chen, Evan C., Yiwen Liu, Ilene Galinsky, et al.. (2024). Dual Bclxl and BCL2 Inhibition with Navitoclax (NAV), Venetoclax (VEN), and Decitabine (DEC) for Advanced Myeloid Neoplasms (MN): Safety and Biological Activity in a Phase 1 Study. Blood. 144(Supplement 1). 4580–4580. 1 indexed citations

Stahl, Maximilian, Yiwen Liu, Eric S. Winer, et al.. (2023). Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia. Leukemia Research. 132. 107351–107351. 2 indexed citations

Chen, Evan C. & Jacqueline S. Garcia. (2023). Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies. Acta Haematologica. 147(2). 198–218. 7 indexed citations

10.

Chen, Evan C., et al.. (2023). Targeted Therapy for MPNs: Going Beyond JAK Inhibitors. Current Hematologic Malignancy Reports. 18(3). 41–55. 2 indexed citations

11.

Shimony, Shai, Jacqueline S. Garcia, Evan C. Chen, et al.. (2023). Molecular Ontogeny in AML Is Both Prognostic and Predictive in Patients Treated with Hypomethylating Agents Plus Venetoclax. Blood. 142(Supplement 1). 977–977. 3 indexed citations

12.

Shimony, Shai, Jan Philipp Bewersdorf, Rory M. Shallis, et al.. (2023). What Is the Optimal Treatment Modality in Molecularly Defined Secondary AML? a Multicenter Cohort Study. Blood. 142(Supplement 1). 1478–1478. 2 indexed citations

13.

Chen, Evan C., et al.. (2022). Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single‐institution experience. Haemophilia. 29(1). 84–89. 10 indexed citations

14.

Chen, Evan C., Geoffrey Fell, Olga Pozdnyakova, et al.. (2022). Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical and Clinical Findings, and Signal Transduction Correlates. Clinical Cancer Research. 29(5). 878–887. 6 indexed citations

15.

Chen, Evan C., Yiwen Liu, Eric S. Winer, et al.. (2022). Outcomes of antifungal prophylaxis for newly diagnosed AML patients treated with a hypomethylating agent and venetoclax. Leukemia & lymphoma. 63(8). 1934–1941. 21 indexed citations

16.

Chen, Evan C., Shuli Li, Ann-Kathrin Eisfeld, et al.. (2021). Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(6). 479.e1–479.e7. 10 indexed citations

17.

Chen, Evan C., et al.. (2018). Incident adverse events following therapy for acute promyelocytic leukemia. Leukemia Research Reports. 9. 79–83. 7 indexed citations

18.

Chen, Evan C., Amir T. Fathi, & Andrew M. Brunner. (2018). Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML. OncoTargets and Therapy. Volume 11. 3425–3434. 42 indexed citations

19.

Chen, Evan C., Gabriela Hobbs, Ashley Perry, et al.. (2017). The Impact of Antimicrobial Prophylaxis during Induction Chemotherapy for Acute Myeloid Leukemia in the Current Era. Blood. 130. 2586–2586. 1 indexed citations

20.

Chen, Evan C., Tomer Kalisky, Santosh K. Gupta, et al.. (2015). KIT Signaling Promotes Growth of Colon Xenograft Tumors in Mice and Is Up-Regulated in a Subset of Human Colon Cancers. Gastroenterology. 149(3). 705–717.e2. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact